NCT01320735View on ClinicalTrials.gov

Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Prostate Cancer
Sponsors

Collaborators (1)

Almedis
All Listed Sponsors
collaborator

Almedis

INDUSTRY

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY